TITLE

The contribution of acidosis to renal osteodystrophy

AUTHOR(S)
Bushinsky, David A.
PUB. DATE
June 1995
SOURCE
Kidney International;Jun1995, Vol. 47 Issue 6, p1816
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the contribution of acidosis to renal osteodystrophy. Types of bone disorders observed in patients with end-stage renal disease; Increase in the serum parathyroid hormone brought by the declining renal function; Role of cellular activity in proton-mediated bone resorption; Cause of calcium release and hydrogen ion buffering during acute metabolic acidosis; Evidence for bone involvement in chronic acidosis.
ACCESSION #
15019422

 

Related Articles

  • Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Goodman, William G.; Jüppner, Harald; Salusky, Isidro B.; Sherrard, Donald J.; Jüppner, Harald // Kidney International;Jan2003, Vol. 63 Issue 1, p1 

    Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Reliable measurements of parathyroid hormone (PTH) concentrations in serum or plasma are critical for the appropriate diagnosis and management of patients with renal osteodystrophy. With the introduction...

  • Searching the optimal PTH target range in children undergoing peritoneal dialysis: New insights from international cohort studies. Haffner, Dieter; Schaefer, Franz // Pediatric Nephrology;Apr2013, Vol. 28 Issue 4, p537 

    The treatment of the mineral and bone disorder associated with chronic kidney disease (CKD-MBD) remains a major challenge in pediatric patients. The principal aims of therapeutic measures are not only to prevent the debilitating skeletal complications and to achieve normal growth but also to...

  • Molecular mechanisms of secondary hyperparathyroidism. Silver, J.; Kilav, R.; Sela-Brown, A.; Naveh-Many, T. // Pediatric Nephrology;Jul2000, Vol. 14 Issue 7, p626 

    Secondary hyperparathyroidism is a frequent complication of chronic renal failure (CRF) and a major factor in the pathogenesis of renal osteodystrophy. A high serum phosphate, decreased levels of serum 1,25(OH)[sub 2] D[sub 3] and the subsequently low serum calcium are the major metabolic...

  • Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Waller, Simon; Ledermann, Sarah; Trompeter, Richard; van’t Hoff, William; Ridout, Deborah; Rees, Lesley // Pediatric Nephrology;Dec2003, Vol. 18 Issue 12, p1236 

    The optimum range for parathyroid hormone (PTH) levels in children with chronic renal failure (CRF) remains undefined. We aimed to determine growth velocity in children with CRF managed with normal PTH levels. We performed a retrospective case note review of 99 children (77 boys), with a...

  • Unresponsiveness of bone to PTH in aluminum-related renal osteodystrophy. Kawaguchi, Yoshindo; Oda, Yoshitaka; Imamura, Noritugu; Shigematu, Takashi; Kimura, Yasuo; Aizawa, Sumio; Fujimaki, Hiroshi; Shoji, Ryo; Tsukui, Itsupei; Ogura, Yosuke; Miyahara, Tadashi // Kidney International Supplement;Feb1986, Issue 18, pS-49 

    Investigates the relationship between parathyroid hormone (PTH) and bone in a model of aluminum-related renal osteodystrophy. Effect of the ingestion of aluminum in the presence of renal impairment on aluminum concentrations in the blood and tissues; Evidence of a low turnover rate of bone...

  • Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. Siomou, Ekaterini; Challa, Anna; Printza, Nikoleta; Giapros, Vasileios; Petropoulou, Fotini; Mitsioni, Andromachi; Papachristou, Fotios; Stefanidis, Constantinos // Pediatric Nephrology;Jul2011, Vol. 26 Issue 7, p1105 

    Osteoprotegerin (OPG), receptor activator of the nuclear factor κB ligand (RANKL) and fibroblast growth factor-23 (FGF-23) play a central role in renal osteodystrophy. We evaluated OPG/RANKL and FGF-23 levels in 51 children with chronic kidney disease (CKD) [ n = 26 stage 3 or 4 (CKD3-4) and...

  • Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. Gokal, Raman; Ramos, Jose M.; Ellis, Hewett A.; Parkinson, Ian; Sweetman, Vicky; Dewar, Jim; Ward, Michael K.; Kerr, David N. S. // Kidney International;Jan1983, Vol. 23 Issue 1, p15 

    The article presents data on the improvement of histological renal osteodystrophy in continuous ambulatory peritoneal dialysis patients and its relation to serum concentration of calcium, phosphate, 25 hydroxycholecalciferol and immunoreactive parathormone. According to the author, renal...

  • Vascular calcification: Hardening of the evidence. Moe, S. M. // Kidney International;Nov2006, Vol. 70 Issue 9, p1535 

    In the past several years, basic-science studies have shown that vascular calcification is an active, cell-mediated process. It is increased in the uremic milieu and with hyperphosphatemia and therefore should be preventable. Additional advances in imaging techniques have facilitated the...

  • Parathyroid hormone and its fragments in children with chronic renal failure. Waller, Simon; Reynolds, Anthony; Ridout, Deborah; Cantor, Tom; Gao, Ping; Rees, Lesley // Pediatric Nephrology;Dec2003, Vol. 18 Issue 12, p1242 

    Parathyroid hormone (PTH) immunoradiometric assays (IRMA) exhibit cross-reactivity between 1-84 PTH and long carboxyl-terminal-PTH (C-PTH) molecules. C-PTH antagonizes the biological actions of 1-84 PTH and circulates in excess in chronic renal failure (CRF), partially explaining why...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics